NipahVR: a resource of multi-targeted putative therapeutics and epitopes for the Nipah virus

Abstract Nipah virus (NiV) is an emerging and priority pathogen from the Paramyxoviridae family with a high fatality rate. It causes various diseases such as respiratory ailments and encephalitis and poses a great threat to humans and livestock. Despite various efforts, there is no approved antiviral treatment available. Therefore, to expedite and assist the research, we have developed an integrative resource NipahVR (http://bioinfo.imtech.res.in/manojk/nipahvr/) for the multi-targeted putative therapeutics and epitopes for NiV. It is structured into different sections, i.e. genomes, codon usage, phylogenomics, molecular diagnostic primers, therapeutics (siRNAs, sgRNAs, miRNAs) and vaccine epitopes (B-cell, CTL, MHC-I and -II binders). Most decisively, potentially efficient therapeutic regimens targeting different NiV proteins and genes were anticipated and projected. We hope this computational resource would be helpful in developing combating strategies against this deadly pathogen. Database URL: http://bioinfo.imtech.res.in/manojk/nipahvr/

[1]  Mary E. Wilson,et al.  Transmission of human infection with Nipah virus. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Stephen P. Luby,et al.  Foodborne Transmission of Nipah Virus, Bangladesh , 2006, Emerging infectious diseases.

[3]  B. He,et al.  4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency. , 2017, Antiviral research.

[4]  Sudhir Kumar,et al.  MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. , 2016, Molecular biology and evolution.

[5]  M. Knörnschild,et al.  Bats host major mammalian paramyxoviruses , 2012, Nature Communications.

[6]  L. Lambeth,et al.  Inhibition of Henipavirus infection by RNA interference , 2008, Antiviral Research.

[7]  K. Chua,et al.  Treatment of acute Nipah encephalitis with ribavirin , 2001, Annals of neurology.

[8]  H. Feldmann,et al.  Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. , 2014, Vaccine.

[9]  R. Tiwari,et al.  Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects. , 2018, Current drug metabolism.

[10]  H. Contamin,et al.  Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection , 2006, Antimicrobial Agents and Chemotherapy.

[11]  C. Broder,et al.  Hendra virus and Nipah virus animal vaccines. , 2016, Vaccine.

[12]  G. Milligan,et al.  Status of vaccine research and development of vaccines for Nipah virus. , 2016, Vaccine.

[13]  Firoz Ahmed,et al.  Designing of Highly Effective Complementary and Mismatch siRNAs for Silencing a Gene , 2011, PloS one.

[14]  J. Epstein,et al.  Henipavirus Infection in Fruit Bats (Pteropus giganteus), India , 2008, Emerging infectious diseases.

[15]  Oscar A. Negrete,et al.  EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus , 2005, Nature.

[16]  J. A. Comer,et al.  Nipah Virus-associated Encephalitis Outbreak, Siliguri, India , 2006, Emerging infectious diseases.

[17]  Jeffry D. Sander,et al.  CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.

[18]  Chun-ching Lin,et al.  Antiviral Natural Products and Herbal Medicines , 2014, Journal of Traditional and Complementary Medicine.

[19]  V. Arankalle,et al.  Genomic Characterization of Nipah Virus , 2011 .

[20]  Hyejin Yoon,et al.  PrimerDesign-M: a multiple-alignment based multiple-primer design tool for walking across variable genomes , 2015, Bioinform..

[21]  D. S. Patil,et al.  Nipah virus: A review on epidemiological characteristics and outbreaks to inform public health decision making. , 2019, Journal of infection and public health.

[22]  Abid Qureshi,et al.  VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses , 2013, Journal of Translational Medicine.

[23]  Harinder Singh,et al.  Improved Method for Linear B-Cell Epitope Prediction Using Antigen’s Primary Sequence , 2013, PloS one.

[24]  Gajendra P. S. Raghava,et al.  Prediction of Immunomodulatory potential of an RNA sequence for designing non-toxic siRNAs and RNA-based vaccine adjuvants , 2016, Scientific Reports.

[25]  C. Broder,et al.  Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody , 2014, Science Translational Medicine.

[26]  W. Bellini,et al.  Molecular biology of Hendra and Nipah viruses. , 2001, Microbes and infection.

[27]  Yun Zhang,et al.  ViPR: an open bioinformatics database and analysis resource for virology research , 2011, Nucleic Acids Res..

[28]  P. Poirazi,et al.  MatureBayes: A Probabilistic Algorithm for Identifying the Mature miRNA within Novel Precursors , 2010, PloS one.

[29]  Lin-Fa Wang,et al.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Adeeba Kamarulzaman,et al.  Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia , 1999, The Lancet.

[31]  V. R. Rajendran,et al.  Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018 , 2019, Emerging infectious diseases.

[32]  Manuel A. S. Santos,et al.  Comparative context analysis of codon pairs on an ORFeome scale , 2005, Genome Biology.

[33]  W. Bellini,et al.  Molecular characterization of Nipah virus, a newly emergent paramyxovirus. , 2000, Virology.

[34]  A. Peterson.  Mapping Risk of Nipah Virus Transmission Across Asia and Across Bangladesh , 2015, Asia-Pacific journal of public health.

[35]  W. Bellini,et al.  Functional properties of the fusion and attachment glycoproteins of Nipah virus. , 2002, Virology.

[36]  P. Rota,et al.  A review of Nipah and Hendra viruses with an historical aside. , 2011, Virus research.

[37]  Tchoyoson C. C. Lim,et al.  Nipah Virus Infection , 2018, Journal of Clinical Microbiology.

[38]  E. Postnikova,et al.  A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model , 2017, npj Vaccines.

[39]  S. Luby.  The pandemic potential of Nipah virus. , 2013, Antiviral research.

[40]  C. Broder,et al.  A treatment for and vaccine against the deadly Hendra and Nipah viruses. , 2013, Antiviral research.

[41]  C. Broder,et al.  Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine , 2006, Journal of Virology.

[42]  Chayan Kumar Saha,et al.  In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses. , 2017, Asian Pacific journal of tropical medicine.

[43]  Md. Rezaul Islam,et al.  Prediction of Epitope-Based Peptides for the Utility of Vaccine Development from Fusion and Glycoprotein of Nipah Virus Using In Silico Approach , 2014, Adv. Bioinformatics.

[44]  Sophie Molia,et al.  Nipah Virus in Lyle's Flying Foxes, Cambodia , 2005, Emerging infectious diseases.

[45]  Gajendra P. S. Raghava,et al.  ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..

[46]  A. Venkatesan,et al.  Epitope‐based immunoinformatics approach on RNA‐dependent RNA polymerase (RdRp) protein complex of Nipah virus (NiV) , 2018, Journal of cellular biochemistry.

[47]  Hans Bitter,et al.  ViralZone: recent updates to the virus knowledge resource , 2012, Nucleic Acids Res..

[48]  V. R. Rajendran,et al.  Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018. , 2018, The Journal of infectious diseases.

[49]  V. Arankalle,et al.  Genomic Characterization of Nipah Virus, West Bengal, India , 2011, Emerging infectious diseases.

[50]  Sandra Diederich,et al.  A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion. , 2009, Journal of medicinal chemistry.

[51]  Benhur Lee,et al.  Favipiravir (T-705) protects against Nipah virus infection in the hamster model , 2018, Scientific Reports.

[52]  Stephen P. Luby,et al.  Person-to-Person Transmission of Nipah Virus in a Bangladeshi Community , 2007, Emerging infectious diseases.

[53]  K. S. Gill,et al.  Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. , 2006, The Indian journal of medical research.

[54]  J. Yadav,et al.  Emerging trends of Nipah virus: A review , 2018, Reviews in medical virology.

[55]  David S. Weiss,et al.  Cas9-mediated targeting of viral RNA in eukaryotic cells , 2015, Proceedings of the National Academy of Sciences.

[56]  M. Ciccozzi,et al.  Origin and evolution of Nipah virus , 2016, Journal of medical virology.

[57]  H. Field,et al.  Nipah virus: a recently emergent deadly paramyxovirus. , 2000, Science.

[58]  S. Nichol,et al.  Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. , 2012, The American journal of tropical medicine and hygiene.

[59]  Supaporn Wacharapluesadee,et al.  Bat Nipah Virus, Thailand , 2005, Emerging infectious diseases.

[60]  Archit Kumar,et al.  Computational Identification of Inhibitors Using QSAR Approach Against Nipah Virus , 2019, Front. Pharmacol..

[61]  Akanksha Rajput,et al.  ge-CRISPR - An integrated pipeline for the prediction and analysis of sgRNAs genome editing efficiency for CRISPR/Cas system , 2016, Scientific Reports.

[62]  Gajendra P. S. Raghava,et al.  ProPred1: Prediction of Promiscuous MHC Class-I Binding Sites , 2003, Bioinform..

[63]  A. Grundhoff,et al.  Identification of viral microRNAs. , 2007, Methods in enzymology.

[64]  Abid Qureshi,et al.  ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis , 2016, Scientific Reports.

[65]  Gajendra P.S. Raghava,et al.  Prediction of CTL epitopes using QM, SVM and ANN techniques. , 2004, Vaccine.